Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.

NCT04501367 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitrectomy
Macular Pucker
Retinal Edema

Interventions

DRUG: Dexamethasone Intracanalicular Insert, 0.4 mg
DRUG: Dexamethasone Intracanalicular Insert, 0.4 mg
DRUG: Prednisone acetate 1%

Sponsor

Kovach Eye Institute